Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Liver Transplantation”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Testing effectiveness (Phase 2)Ended earlyNCT03781414
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

Who this might be right for
Liver Transplant Rejection
Novartis Pharmaceuticals 129
Post-approval studies (Phase 4)Ended earlyNCT01371344
What this trial is testing

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 47
Large-scale testing (Phase 3)Study completedNCT00719745
What this trial is testing

Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Astellas Pharma Inc 74
Not applicableStudy completedNCT00710801
What this trial is testing

Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

Who this might be right for
Hepatitis C Virus
University of Alberta 40
Post-approval studies (Phase 4)Looking for participantsNCT05089604
What this trial is testing

Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations

Who this might be right for
Liver TransplantationImmunosuppressionNeurotoxicity+2 more
University of British Columbia 124
Post-approval studies (Phase 4)Looking for participantsNCT05242315
What this trial is testing

Extended-Release Tacrolimus Following Liver Transplantation

Who this might be right for
Liver Transplant; ComplicationsRenal InsufficiencyImmunosuppressant Adverse Reaction+2 more
University of Alberta 94
Post-approval studies (Phase 4)Study completedNCT00538265
What this trial is testing

Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation

Who this might be right for
Liver Transplantation
University Hospital, Toulouse 100
Large-scale testing (Phase 3)Study completedNCT00149890
What this trial is testing

Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids

Who this might be right for
Liver TransplantationInfection
Novartis 77
Post-approval studies (Phase 4)Study completedNCT01551212
What this trial is testing

Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 339
Post-approval studies (Phase 4)Study completedNCT05153915
What this trial is testing

Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Who this might be right for
Liver TransplantationKidney Transplantation
Astellas Pharma China, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01614665
What this trial is testing

Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT06019507
What this trial is testing

TCD601 in the Induction of Tolerance in de Novo Liver Transplantation

Who this might be right for
Liver Transplantation
ITB-Med LLC 12
Post-approval studies (Phase 4)Study completedNCT01018914
What this trial is testing

Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients

Who this might be right for
Liver Transplantation
Astellas Pharma Inc 44
Testing effectiveness (Phase 2)UnknownNCT00890253
What this trial is testing

Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation

Who this might be right for
Liver TransplantationChronic Renal Insufficiency
Armin Goralczyk 29
Large-scale testing (Phase 3)Study completedNCT00720408
What this trial is testing

Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

Who this might be right for
Liver TransplantationTransplantation ImmunologyHost vs Graft Reaction
Astellas Pharma Inc 48
Testing effectiveness (Phase 2)Study completedNCT01146808
What this trial is testing

Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver

Who this might be right for
Hepatitis BLiver Transplantation
Columbia University 16
Post-approval studies (Phase 4)Study completedNCT01339468
What this trial is testing

Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation

Who this might be right for
Liver Transplantation
Astellas Pharma Inc 100
Post-approval studies (Phase 4)Study completedNCT00343226
What this trial is testing

An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.

Who this might be right for
Liver Transplantation
Novartis 48
Large-scale testing (Phase 3)Study completedNCT00378014
What this trial is testing

Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 276
Post-approval studies (Phase 4)Study completedNCT00332462
What this trial is testing

Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 34
Load More Results